Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Ophthalmic Surgery, Lasers & Imaging Retina|April 22, 2026
Universal Newborn Eye Screening in São Paulo, BrazilPauline Scherm, Devi K Schwartz, Marcelo Alexandre Agra Cavalcante Costa, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|August 7, 2015
Association Between Growth of Geographic Atrophy and the Complement Factor I LocusZohar Yehoshua, Carlos Alexandre de Amorim Garcia Filho, Renata Portella Nunes, et al.
The British Journal of Ophthalmology|August 17, 2012
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategyAndrew A Moshfeghi, Virgilio Morales-Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 27, 2015
Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of TreatmentNinel Z Gregori, Harry W Flynn, Stephen G Schwartz, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 11, 2010
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitisLudimila L Cavalcante, Milena L Cavalcante, Timothy G Murray, et al.
The American Journal of Medicine|November 3, 2015
Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular DegenerationMurray H Brilliant, Kamyar Vaziri, Thomas B Connor, et al.
Pageof 10